AIM
ARRY

Acrospire Investment Management’s Array Biopharma Inc ARRY Stock Holding History

Acrospire Investment Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,286
Closed -$19K – 1870
2017
Q2 		$19K Sell
2,286
-6,700
-75% -$54.8K 0.02% 1568
2017
Q1 		$80K Sell
8,986
-8,990
-50% -$95.7K 0.07% 489
2016
Q4 		$158K Buy
+17,976
New +$132K 0.07% 561

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Acrospire Investment Management's ARRY Position: Q3 2017 in Review

Acrospire Investment Management sold out of Array Biopharma Inc (ARRY) in Q3 2017, closing a stake of 2,286 shares — an estimated $19K sold.

Acrospire Investment Management first reported a position in ARRY in Q4 2016 and held it in 3 quarters. The position peaked at $158K in Q4 2016. 184 funds tracked by Wall St. Rank hold ARRY as of Q3 2017.

  • Acrospire Investment Management reported no remaining Array Biopharma Inc position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 2,286 Array Biopharma Inc shares in Q3 2017, an estimated $19K.
  • Acrospire Investment Management first reported a position in Array Biopharma Inc in Q4 2016 and held it in 3 quarters.
  • Acrospire Investment Management's Array Biopharma Inc position peaked at $158K in Q4 2016.
  • 184 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.